United Therapeutics (UTHR) Short Interest Ratio & Short Volume $284.25 -0.48 (-0.17%) Closing price 04/21/2025 04:00 PM EasternExtended Trading$298.30 +14.05 (+4.94%) As of 04:31 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock United Therapeutics Short Interest DataUnited Therapeutics (UTHR) has a short interest of 1.71 million shares, representing 3.88% of the float (the number of shares available for trading by the public). This marks a -6.56% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.6, indicating that it would take 3.6 days of the average trading volume of 450,063 shares to cover all short positions.Current Short Interest1,710,000 sharesPrevious Short Interest1,830,000 sharesChange Vs. Previous Month-6.56%Dollar Volume Sold Short$527.14 millionShort Interest Ratio3.6 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares44,912,000 sharesFloat Size44,090,000 sharesShort Percent of Float3.88%Today's Trading Volume338,558 sharesAverage Trading Volume450,063 sharesToday's Volume Vs. Average75% Short Selling United Therapeutics? Sign up to receive the latest short interest report for United Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartUTHR Short Interest Over TimeUTHR Days to Cover Over TimeUTHR Percentage of Float Shorted Over Time United Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20251,710,000 shares $527.14 million -6.6%3.9%3.6 $308.27 3/15/20251,830,000 shares $562.25 million -25.6%4.2%4.1 $307.24 2/28/20252,460,000 shares $787.10 million +18.8%5.6%6.1 $319.96 2/15/20252,070,000 shares $767.10 million +3.0%4.7%5.8 $370.58 1/31/20252,010,000 shares $705.85 million +1.5%4.6%6.3 $351.17 1/15/20251,980,000 shares $716.05 million +3.1%4.5%6.2 $361.64 12/31/20241,920,000 shares $677.45 million -14.3%4.4%6.1 $352.84 12/15/20242,240,000 shares $810.45 million +7.7%5.1%6.8 $361.81 11/30/20242,080,000 shares $770.62 million -5.9%4.8%6.1 $370.49 11/15/20242,210,000 shares $802.78 million -3.9%5.0%6.1 $363.25 Get the Latest News and Ratings for UTHR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for United Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/20242,300,000 shares $860.13 million +5.0%5.2%5.8 $373.97 10/15/20242,190,000 shares $787.46 million -2.2%5.0%5.3 $359.57 9/30/20242,240,000 shares $802.70 million -45.1%5.1%5.1 $358.35 9/15/20244,080,000 shares $1.38 billion -0.2%9.3%8.4 $339.12 8/31/20244,090,000 shares $1.49 billion -1.2%9.4%7.8 $363.55 8/15/20244,140,000 shares $1.34 billion +0.5%9.5%7.5 $323.08 7/31/20244,120,000 shares $1.29 billion -1.2%9.4%7.7 $313.29 7/15/20244,170,000 shares $1.36 billion -5.4%9.6%7.4 $327.26 6/30/20244,410,000 shares $1.40 billion +0.9%10.1%7.8 $318.55 6/15/20244,370,000 shares $1.26 billion +12.3%10.0%7.5 $288.06 5/31/20243,890,000 shares $1.07 billion +3.2%9.4%7.2 $275.13 5/15/20243,770,000 shares $1.03 billion -2.1%9.1%7.2 $272.69 4/30/20243,850,000 shares $902.17 million -10.9%9.4%7.4 $234.33 4/15/20244,320,000 shares $1.02 billion -11.7%10.0%9.4 $235.08 3/31/20244,890,000 shares $1.12 billion +154.7%11.3%11.3 $229.72 3/15/20241,920,000 shares $452.70 million +64.1%4.4%4.7 $235.78 2/29/20241,170,000 shares $264.00 million +0.9%2.7%3 $225.64 2/15/20241,160,000 shares $248.87 million +11.5%2.7%3.3 $214.54 1/31/20241,040,000 shares $223.37 million -11.9%N/A3.3 $214.78 1/15/20241,180,000 shares $258.48 million +7.3%N/A3.6 $219.05 12/31/20231,100,000 shares $241.88 million -15.4%N/A3.5 $219.89 12/15/20231,300,000 shares $320.39 million +14.0%N/A4.2 $246.45 11/30/20231,140,000 shares $273.60 million +0.9%N/A4.2 $240.00 11/15/20231,130,000 shares $259.06 million +4.6%N/A4.4 $229.26 10/31/20231,080,000 shares $240.69 million +4.9%N/A3.6 $222.86 10/15/20231,030,000 shares $240.15 million +7.1%N/A3.4 $233.16 9/30/2023962,200 shares $217.33 million -13.3%N/A3.1 $225.87 9/15/20231,110,000 shares $244.47 million +1.8%N/A3.4 $220.24 8/31/20231,090,000 shares $244.55 million -42.3%N/A3.3 $224.36 8/15/20231,890,000 shares $445.53 million +94.6%N/A5.1 $235.73Now I look stupid. Real stupid... (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 7/31/2023971,100 shares $235.71 million -2.2%N/A2.7 $242.72 7/15/2023992,600 shares $230.28 million -8.1%N/A2.6 $232.00 6/30/20231,080,000 shares $238.41 million -5.3%N/A2.8 $220.75 6/15/20231,140,000 shares $261.73 million +9.6%N/A2.7 $229.59 5/31/20231,040,000 shares $218.13 million -22.4%N/A2.2 $209.74 5/15/20231,340,000 shares $287.30 million -8.2%N/A2.4 $214.40 4/30/20231,460,000 shares $335.99 million +6.6%N/A2.5 $230.13 4/15/20231,370,000 shares $313.35 million -3.5%N/A2.5 $228.72 3/31/20231,420,000 shares $318.02 million +6.0%N/A2.6 $223.96 3/15/20231,340,000 shares $291.45 million +0.8%N/A2.6 $217.50 2/28/20231,330,000 shares $327.23 million -5.0%N/A2.8 $246.04 2/15/20231,400,000 shares $354.70 million +11.1%3.1%3.6 $253.36 1/31/20231,260,000 shares $331.59 million -3.8%2.8%3.5 $263.17 1/15/20231,310,000 shares $341.96 million -1.5%2.9%3.4 $261.04 12/30/20221,330,000 shares $369.86 million +20.9%3.0%3.5 $278.09 12/15/20221,100,000 shares $303.44 million -17.9%2.5%3 $275.85 11/30/20221,340,000 shares $375.05 million -5.0%3.0%3.6 $279.89 11/15/20221,410,000 shares $365.36 million +6.8%3.2%3.8 $259.12 10/31/20221,320,000 shares $304.30 million -7.0%3.0%3.5 $230.53 10/15/20221,420,000 shares $307.34 million +6.8%3.2%3.9 $216.44 9/30/20221,330,000 shares $278.48 million +7.3%3.0%3.5 $209.38 9/15/20221,240,000 shares $273.59 million +41.4%2.8%3.1 $220.64 8/31/2022877,000 shares $198.75 million -18.0%2.0%2 $226.62 8/15/20221,070,000 shares $233.65 million +1.9%2.4%2.2 $218.36 7/31/20221,050,000 shares $242.62 million -11.0%2.4%2.1 $231.07 7/15/20221,180,000 shares $283.29 million -3.3%2.7%2.4 $240.08 6/30/20221,220,000 shares $287.48 million -6.9%2.8%2.5 $235.64 6/15/20221,310,000 shares $288.32 million -16.0%3.0%2.6 $220.09 5/31/20221,560,000 shares $359.33 million -12.4%3.5%3.2 $230.34 5/15/20221,780,000 shares $326.52 million +58.9%4.0%3.6 $183.44 4/30/20221,120,000 shares $198.87 million +8.7%2.5%2.5 $177.56 4/15/20221,030,000 shares $197.67 million -38.3%2.3%2.3 $191.91 3/31/20221,670,000 shares $299.61 million +67.0%3.8%3.5 $179.41 3/15/20221,000,000 shares $178.82 million -32.0%2.3%2.3 $178.82 2/28/20221,470,000 shares $244.31 million -8.1%3.3%3.4 $166.20 2/15/20221,600,000 shares $326.86 million -9.6%3.6%3.8 $204.29 1/31/20221,770,000 shares $357.31 million +37.2%4.0%4.5 $201.87 1/15/20221,290,000 shares $276.01 million +19.4%2.9%3.1 $213.96 12/31/20211,080,000 shares $233.37 million -21.7%2.5%2.7 $216.08 12/15/20211,380,000 shares $269.96 million -22.0%3.1%3.4 $195.62 11/30/20211,770,000 shares $335.42 million -5.9%4.0%4.6 $189.50 11/15/20211,880,000 shares $385.46 million -21.3%4.3%5.1 $205.03 10/29/20212,390,000 shares $455.92 million +18.3%5.4%6.5 $190.76 10/15/20212,020,000 shares $377.88 million -14.4%4.5%5.5 $187.07 9/30/20212,360,000 shares $435.61 million -4.5%5.3%7 $184.58 9/15/20212,470,000 shares $504.55 million -23.8%5.6%7.6 $204.27 8/31/20213,240,000 shares $696.21 million +68.8%7.4%9.8 $214.88 8/13/20211,920,000 shares $389.03 million +18.5%4.4%5.4 $202.62 7/30/20211,620,000 shares $294.73 million -3.6%3.7%4.7 $181.93 7/15/20211,680,000 shares $309.44 million -4.6%3.8%5.5 $184.19Now I look stupid. Real stupid... (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 6/30/20211,760,000 shares $315.76 million No Change4.0%5.4 $179.41 6/15/20211,760,000 shares $314.07 million +0.6%4.0%4.6 $178.45 5/28/20211,750,000 shares $325.33 million -3.9%4.0%4.5 $185.90 5/14/20211,820,000 shares $352.66 million -9.9%4.2%4.8 $193.77 4/30/20212,020,000 shares $412.56 million No Change4.6%5.4 $204.24 4/15/20212,020,000 shares $409.62 million -13.7%4.7%5.5 $202.78 3/31/20212,340,000 shares $387.20 million +3.1%5.4%6 $165.47 3/15/20212,270,000 shares $362.07 million +18.2%5.2%6.7 $159.50 2/26/20211,920,000 shares $324.10 million +10.3%4.4%5.7 $168.80 2/12/20211,740,000 shares $294.98 million -1.1%4.0%5.4 $169.53 1/29/20211,760,000 shares $289.33 million +1.2%4.1%5.2 $164.39 1/15/20211,740,000 shares $291.03 million -7.9%4.0%4.4 $167.26 12/31/20201,890,000 shares $281.01 million -5.0%4.4%4.5 $148.68 12/15/20201,990,000 shares $284.85 million -3.9%4.6%4.9 $143.14 11/30/20202,070,000 shares $280.57 million -7.2%4.8%5.2 $135.54 10/30/20202,520,000 shares $328.23 million +12.5%5.8%6.8 $130.25 10/15/20202,240,000 shares $246.31 million +9.8%5.2%6.9 $109.96 9/30/20202,040,000 shares $206.04 million +10.9%4.7%7 $101.00 9/15/20201,840,000 shares $194.58 million No Change4.3%5.4 $105.75 8/31/20201,840,000 shares $196.81 million +10.8%4.3%4.7 $106.96 8/14/20201,660,000 shares $181.72 million -0.6%3.8%3.7 $109.47 7/31/20201,670,000 shares $186.15 million -13.5%3.9%3.2 $111.47 7/15/20201,930,000 shares $228.45 million -17.2%4.6%3.2 $118.37 6/30/20202,330,000 shares $281.93 million -26.5%5.5%3.7 $121.00 6/15/20203,170,000 shares $365.88 million -1.9%7.5%4.9 $115.42 5/29/20203,230,000 shares $380.98 million +5.6%7.6%4.6 $117.95 5/15/20203,060,000 shares $356.06 million -14.0%7.2%4.2 $116.36 4/30/20203,560,000 shares $384.37 million +16.3%8.4%5.1 $107.97 UTHR Short Interest - Frequently Asked Questions What is United Therapeutics' current short interest? Short interest is the volume of United Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 1,710,000 shares of UTHR short. 3.88% of United Therapeutics' shares are currently sold short. Learn More on United Therapeutics' current short interest. What is a good short interest ratio for United Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. UTHR shares currently have a short interest ratio of 4.0. Learn More on United Therapeutics's short interest ratio. Which institutional investors are shorting United Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of United Therapeutics: Wolverine Trading LLC, Torno Capital LLC, Millennium Management LLC, LMR Partners LLP, Caption Management LLC, Citadel Advisors LLC, Jane Street Group LLC, Parallax Volatility Advisers L.P., Two Sigma Securities LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., Walleye Trading LLC, Walleye Capital LLC, JPMorgan Chase & Co., Twin Tree Management LP, and Genus Capital Management Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for United Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.88% of United Therapeutics' floating shares are currently sold short. Is United Therapeutics' short interest increasing or decreasing? United Therapeutics saw a drop in short interest in March. As of March 31st, there was short interest totaling 1,710,000 shares, a drop of 6.6% from the previous total of 1,830,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is United Therapeutics' float size? United Therapeutics currently has issued a total of 44,912,000 shares. Some of United Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. United Therapeutics currently has a public float of 44,090,000 shares. How does United Therapeutics' short interest compare to its competitors? 3.88% of United Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to United Therapeutics: Alnylam Pharmaceuticals, Inc. (2.34%), Biogen Inc. (2.29%), Incyte Co. (3.77%), BioMarin Pharmaceutical Inc. (2.51%), Exelixis, Inc. (5.49%), Neurocrine Biosciences, Inc. (3.97%), Exact Sciences Co. (6.12%), Halozyme Therapeutics, Inc. (7.54%), Repligen Co. (6.68%), Madrigal Pharmaceuticals, Inc. (23.76%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short United Therapeutics stock? Short selling UTHR is an investing strategy that aims to generate trading profit from United Therapeutics as its price is falling. UTHR shares are trading down $0.48 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against United Therapeutics? A short squeeze for United Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of UTHR, which in turn drives the price of the stock up even further. How often is United Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UTHR, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies ALNY Short Squeeze BIIB Short Squeeze INCY Short Squeeze BMRN Short Squeeze EXEL Short Squeeze NBIX Short Squeeze EXAS Short Squeeze HALO Short Squeeze RGEN Short Squeeze MDGL Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:UTHR) was last updated on 4/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCould this be my downfall?I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThey Scared The Nation And Cashed in on ChaosYou weren’t supposed to notice what just happened. While the headlines screamed about tariffs and Trump, Wa...American Hartford Gold | SponsoredBiggest AI gains still ahead…? (Major announcement coming)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UTHR Stock Free UTHR Stock Alerts